Canada markets open in 7 hours 42 minutes

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
113,100.00-400.00 (-0.35%)
As of 02:27PM KST. Market open.
Currency in KRW

Valuation Measures4

Market Cap (intraday) 1.30T
Enterprise Value 1.96T
Trailing P/E 21.15
Forward P/E 17.54
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.79
Price/Book (mrq)1.03
Enterprise Value/Revenue 1.20
Enterprise Value/EBITDA 19.00

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-9.35%
S&P500 52-Week Change 327.84%
52 Week High 3131,100.00
52 Week Low 393,000.00
50-Day Moving Average 3116,846.00
200-Day Moving Average 3114,171.00

Share Statistics

Avg Vol (3 month) 320.28k
Avg Vol (10 day) 317.41k
Shares Outstanding 511.41M
Implied Shares Outstanding 611.48M
Float 85.45M
% Held by Insiders 151.45%
% Held by Institutions 112.85%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41500
Forward Annual Dividend Yield 41.32%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 40.96
Payout Ratio 41,080.25%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 27, 2023
Last Split Factor 21.05:1
Last Split Date 3Jun 07, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -1.64%
Operating Margin (ttm)-2.21%

Management Effectiveness

Return on Assets (ttm)0.82%
Return on Equity (ttm)-1.27%

Income Statement

Revenue (ttm)1.63T
Revenue Per Share (ttm)142,523.30
Quarterly Revenue Growth (yoy)-1.60%
Gross Profit (ttm)N/A
EBITDA 109.81B
Net Income Avi to Common (ttm)-26.63B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)55.51B
Total Cash Per Share (mrq)4,863.34
Total Debt (mrq)724.02B
Total Debt/Equity (mrq)47.02%
Current Ratio (mrq)1.20
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-5.47B
Levered Free Cash Flow (ttm)-166.64B